
|Articles|January 1, 2005
Drugs, nerve stim offer some relief in IC patients
Please discuss how you treat IC, starting with what you tell patients and when you initiate oral therapy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
BOND-003 Cohort C: Efficacy Results
4
Individualizing androgen pathway therapy in mCSPC
5








